| Steven Brooks Nagelberg, MD | |
|
9501 Roosevelt Blvd, Suite 400, Philadelphia, PA 19114-1025 | |
| (215) 969-9511 | |
| (215) 969-9512 |
| Full Name | Steven Brooks Nagelberg |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 46 Years |
| Location | 9501 Roosevelt Blvd, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619917267 | NPI | - | NPPES |
| 061644 | Other | PA | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD033710E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Heath | Philadelphia, PA | Hospital |
| Holy Redeemer Hospital And Medical Center | Meadowbrook, PA | Hospital |
| Nazareth Hospital | Philadelphia, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aria Health Physician Services | 3577467018 | 418 |
News Archive
Signal researchers in Oulu have developed a mobile phone application that can measure impaired breathing.
The White House's plan to indefinitely detain immigrant families together threatens the care of young children, experts worry, by placing them with an agency with little experience in handling such complex needs.
Amedisys, Inc., one of America's leading home health and hospice nursing companies, today released the results of a review conducted by Marwood Group Advisory, LLC (Marwood). Several months ago Amedisys engaged Marwood, one of the nation's preeminent health care consulting firms, to provide an independent analysis of the Company's procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies.
People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M. D. Anderson Cancer Center.
The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.
› Verified 9 days ago
| Entity Name | Aria Health Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750949806 PECOS PAC ID: 3577467018 Enrollment ID: O20040224000045 |
News Archive
Signal researchers in Oulu have developed a mobile phone application that can measure impaired breathing.
The White House's plan to indefinitely detain immigrant families together threatens the care of young children, experts worry, by placing them with an agency with little experience in handling such complex needs.
Amedisys, Inc., one of America's leading home health and hospice nursing companies, today released the results of a review conducted by Marwood Group Advisory, LLC (Marwood). Several months ago Amedisys engaged Marwood, one of the nation's preeminent health care consulting firms, to provide an independent analysis of the Company's procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies.
People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M. D. Anderson Cancer Center.
The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Brooks Nagelberg, MD 9501 Roosevelt Blvd, Suite 400, Philadelphia, PA 19114-1025 Ph: (215) 969-9511 | Steven Brooks Nagelberg, MD 9501 Roosevelt Blvd, Suite 400, Philadelphia, PA 19114-1025 Ph: (215) 969-9511 |
News Archive
Signal researchers in Oulu have developed a mobile phone application that can measure impaired breathing.
The White House's plan to indefinitely detain immigrant families together threatens the care of young children, experts worry, by placing them with an agency with little experience in handling such complex needs.
Amedisys, Inc., one of America's leading home health and hospice nursing companies, today released the results of a review conducted by Marwood Group Advisory, LLC (Marwood). Several months ago Amedisys engaged Marwood, one of the nation's preeminent health care consulting firms, to provide an independent analysis of the Company's procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies.
People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability, according to researchers from the Department of Epidemiology at The University of Texas M. D. Anderson Cancer Center.
The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterizing glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyze minor glycan species.
› Verified 9 days ago
Philippe Olivier Szapary, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3400 Civic Center Blvd, East Pavilion, 2nd Floor, Philadelphia, PA 19104 Phone: 215-615-4949 | |
Dr. Jamie L. Garfield, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-5864 Fax: 215-707-6867 | |
Maria Esther Escorcia De Leon, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-1622 Fax: 215-707-0943 | |
Cherag Daruwala, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2301 E Allegheny Ave, Suite 190b, Philadelphia, PA 19134 Phone: 215-926-3120 Fax: 215-926-3123 | |
Dr. Robert Burke, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 51 N 39th St, Philadelphia, PA 19104 Phone: 215-662-9436 Fax: 215-243-3208 | |
Eva Hassan Alsheik, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 219 N Broad St, 5th Floor, Philadelphia, PA 19107 Phone: 215-762-6071 | |
Dr. Jason Thomas Ackrivo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-614-0871 |